November/December 2014

March 02, 2015

This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.

March 02, 2015

Less than one-fourth of Part D beneficiaries reported switching plans. Elderly beneficiaries who reported switching did not realize significant savings in prescription costs over nonswitchers.

February 14, 2015

While fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.

February 06, 2015

A budget-impact model illustrates the economic outcomes associated with renoprotective therapy on privately insured patients with advanced kidney disease.

December 16, 2014

The intended audience for this activity consists of medical directors, pharmacy directors, pharmacy benefit managers, and other managed care professionals who are involved with the treatment of patients with acute coronary syndrome.

December 16, 2014

In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.

December 16, 2014

Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.

December 16, 2014

Annual rates of increase in oncology drug utilization, drug price, and plan spending are quantified and potential contributors are explored.

December 16, 2014

The time is now to develop a consensus on how patient needs, health plan sustainability, and government regulations intertwine to create a more patient-focused insurance marketplace.

December 16, 2014